These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 3863815
41. Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. Song WL, Wang M, Ricciotti E, Fries S, Yu Y, Grosser T, Reilly M, Lawson JA, FitzGerald GA. J Biol Chem; 2008 Jan 11; 283(2):1179-88. PubMed ID: 17993463 [Abstract] [Full Text] [Related]
42. The identification of 5beta,7alpha-dihydroxy-11-oxotetranor-prostane-1,16-dioic acid as a urinary metabolite of prostaglandin F2alpha in the rat. Brash AR, Baillie TA. Biochim Biophys Acta; 1979 Feb 26; 572(2):371-5. PubMed ID: 427184 [Abstract] [Full Text] [Related]
43. Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis. Poynard T, Nataf C, Messing B, Modigliani R, Lecompte T, Nicolas P, Dray F, Ferme C. N Engl J Med; 1982 Jul 15; 307(3):186. PubMed ID: 6953312 [No Abstract] [Full Text] [Related]
44. Use of a homologous internal standard for the quantification of the major metabolite of prostaglandin F2 alpha in human urine by multiple ion analysis. Ferretti A, Flanagan VP, Roman JM. Anal Biochem; 1984 Jan 15; 136(1):217-22. PubMed ID: 6711810 [Abstract] [Full Text] [Related]
45. Metabolic disposition of prostaglandin E1 in man. Rosenkranz B, Fischer C, Boeynaems JM, Frölich JC. Biochim Biophys Acta; 1983 Feb 07; 750(2):231-6. PubMed ID: 6683104 [Abstract] [Full Text] [Related]
46. Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans. Diczfalusy U, Kase BF, Alexson SE, Björkhem I. J Clin Invest; 1991 Sep 07; 88(3):978-84. PubMed ID: 1885782 [Abstract] [Full Text] [Related]
47. Chain-shortening of prostaglandin F2 alpha by rat liver peroxisomes. Diczfalusy U, Alexson SE, Pedersen JI. Biochem Biophys Res Commun; 1987 May 14; 144(3):1206-13. PubMed ID: 3472523 [Abstract] [Full Text] [Related]
48. Metabolism of prostaglandin F2 alpha in sheep. Dimov V, Gréen K. Drug Metab Dispos; 1990 May 14; 18(1):107-14. PubMed ID: 1970769 [Abstract] [Full Text] [Related]
49. Identification of the major urinary metabolite of prostaglandin E3 in the rat. Diczfalusy U, Hamberg M. Biochim Biophys Acta; 1986 Oct 03; 878(3):387-93. PubMed ID: 3756200 [Abstract] [Full Text] [Related]
50. The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. Seregi A, Förstermann U, Heldt R, Hertting G. Brain Res; 1985 Jun 24; 337(1):171-4. PubMed ID: 3859353 [Abstract] [Full Text] [Related]
52. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. Rosenkranz B, Fischer C, Weimer KE, Frölich JC. J Biol Chem; 1980 Nov 10; 255(21):10194-8. PubMed ID: 7000774 [Abstract] [Full Text] [Related]
53. An NADP-linked 15-hydroxyprostaglandin dehydrogenase specific for prostaglandin D2 from swine brain. Tokumoto H, Watanabe K, Fukushima D, Shimizu T, Hayaishi O. J Biol Chem; 1982 Nov 25; 257(22):13576-80. PubMed ID: 6958674 [Abstract] [Full Text] [Related]
54. Intact biliary excretion of gastrically administered prostaglandin F2 alpha in rats: developmental differences. Bedrick AD, Wells MA, Ford DL, Koldovský O. Am J Physiol; 1987 Dec 25; 253(6 Pt 1):G787-92. PubMed ID: 3480694 [Abstract] [Full Text] [Related]
55. Prostaglandin D2 is the prevailing prostaglandin in the acute inflammatory exudate of urate arthritis in the chicken. Anhut H, Brune K, Frölich JC, Peskar BA. Br J Pharmacol; 1979 Mar 25; 65(3):357-9. PubMed ID: 570865 [Abstract] [Full Text] [Related]
56. Biochemical and immunological demonstration of prostaglandin D2, E2, and F2 alpha formation from prostaglandin H2 by various rat glutathione S-transferase isozymes. Ujihara M, Tsuchida S, Satoh K, Sato K, Urade Y. Arch Biochem Biophys; 1988 Aug 01; 264(2):428-37. PubMed ID: 3041912 [Abstract] [Full Text] [Related]
57. [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2]. Suzuki H, Sato K, Yoshizumi N, Nishiya I. Nihon Naibunpi Gakkai Zasshi; 1986 Aug 20; 62(8):857-66. PubMed ID: 3465609 [Abstract] [Full Text] [Related]
58. Metabolic disposition of prostacyclin in humans. Brash AR, Jackson EK, Saggese CA, Lawson JA, Oates JA, FitzGerald GA. J Pharmacol Exp Ther; 1983 Jul 20; 226(1):78-87. PubMed ID: 6345756 [Abstract] [Full Text] [Related]
59. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. Schweer H, Watzer B, Seyberth HW, Nüsing RM. J Mass Spectrom; 1997 Dec 20; 32(12):1362-70. PubMed ID: 9423285 [Abstract] [Full Text] [Related]
60. On the metabolism of prostaglandin F 2 in female subjects. Structures of two C 14 metabolites. Granström E. Eur J Biochem; 1972 Feb 20; 25(3):581-9. PubMed ID: 5043324 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]